DE3141894A1 - Reagenz fuer die bestimmung des ristocetin-cofaktors (v. willebrand-faktor) - Google Patents
Reagenz fuer die bestimmung des ristocetin-cofaktors (v. willebrand-faktor)Info
- Publication number
- DE3141894A1 DE3141894A1 DE19813141894 DE3141894A DE3141894A1 DE 3141894 A1 DE3141894 A1 DE 3141894A1 DE 19813141894 DE19813141894 DE 19813141894 DE 3141894 A DE3141894 A DE 3141894A DE 3141894 A1 DE3141894 A1 DE 3141894A1
- Authority
- DE
- Germany
- Prior art keywords
- platelets
- ristocetin
- determining
- reagent
- ristocetin cofactor
- Prior art date
- Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
- Withdrawn
Links
- 108010047303 von Willebrand Factor Proteins 0.000 title abstract description 12
- 239000003153 chemical reaction reagent Substances 0.000 title description 6
- VUOPFFVAZTUEGW-SRXUPNLNSA-N 32p08cbb99 Chemical compound C=1C([C@@H]2C(=O)N[C@@H]([C@@H](C3=CC=C(C=C3)OC=3C=C4C=C(C=3O[C@H]3[C@@H]([C@@H](O)[C@H](O)[C@@H](CO[C@H]5[C@@H]([C@H](O)[C@@H](O)[C@H](C)O5)O)O3)O[C@@H]3[C@H]([C@@H](O)[C@H](O)[C@@H](CO)O3)O[C@H]3[C@H]([C@H](O)[C@H](O)CO3)O)OC3=CC=C(C=C3)[C@@H](O)[C@@H]3C(=O)N[C@@H](C=5C=C(C(=C(O)C=5)C)OC=5C(O)=CC=C(C=5)[C@@H](N)C(=O)N3)C(=O)N[C@H]4C(=O)N2)O[C@@H]2O[C@@H](C)[C@H](O)[C@H](N)C2)C(=O)N[C@@H](C2=CC(O)=C3)C(=O)OC)=CC=C(O)C=1C2=C3O[C@@H]1O[C@H](CO)[C@@H](O)[C@H](O)[C@@H]1O VUOPFFVAZTUEGW-SRXUPNLNSA-N 0.000 claims abstract description 6
- 239000003795 chemical substances by application Substances 0.000 claims abstract description 6
- 108010062729 ristocetin A Proteins 0.000 claims abstract description 6
- 239000000137 peptide hydrolase inhibitor Substances 0.000 claims abstract description 5
- 102000004169 proteins and genes Human genes 0.000 claims description 7
- 108090000623 proteins and genes Proteins 0.000 claims description 7
- 150000001413 amino acids Chemical class 0.000 claims description 2
- 239000000084 colloidal system Substances 0.000 claims description 2
- MUCZHBLJLSDCSD-UHFFFAOYSA-N diisopropyl fluorophosphate Chemical compound CC(C)OP(F)(=O)OC(C)C MUCZHBLJLSDCSD-UHFFFAOYSA-N 0.000 claims description 2
- 230000001681 protective effect Effects 0.000 claims description 2
- MTCFGRXMJLQNBG-UHFFFAOYSA-N Serine Natural products OCC(N)C(O)=O MTCFGRXMJLQNBG-UHFFFAOYSA-N 0.000 claims 1
- 238000004040 coloring Methods 0.000 claims 1
- 229960005051 fluostigmine Drugs 0.000 claims 1
- 239000003112 inhibitor Substances 0.000 claims 1
- 239000000975 dye Substances 0.000 abstract description 6
- 229940124158 Protease/peptidase inhibitor Drugs 0.000 abstract description 4
- 239000000725 suspension Substances 0.000 description 12
- 238000012360 testing method Methods 0.000 description 12
- 230000004520 agglutination Effects 0.000 description 7
- 238000000034 method Methods 0.000 description 7
- WSFSSNUMVMOOMR-UHFFFAOYSA-N Formaldehyde Chemical compound O=C WSFSSNUMVMOOMR-UHFFFAOYSA-N 0.000 description 6
- 108010081391 Ristocetin Proteins 0.000 description 6
- BGTFCAQCKWKTRL-YDEUACAXSA-N chembl1095986 Chemical compound C1[C@@H](N)[C@@H](O)[C@H](C)O[C@H]1O[C@@H]([C@H]1C(N[C@H](C2=CC(O)=CC(O[C@@H]3[C@H]([C@@H](O)[C@H](O)[C@@H](CO)O3)O)=C2C=2C(O)=CC=C(C=2)[C@@H](NC(=O)[C@@H]2NC(=O)[C@@H]3C=4C=C(C(=C(O)C=4)C)OC=4C(O)=CC=C(C=4)[C@@H](N)C(=O)N[C@@H](C(=O)N3)[C@H](O)C=3C=CC(O4)=CC=3)C(=O)N1)C(O)=O)=O)C(C=C1)=CC=C1OC1=C(O[C@@H]3[C@H]([C@H](O)[C@@H](O)[C@H](CO[C@@H]5[C@H]([C@@H](O)[C@H](O)[C@@H](C)O5)O)O3)O[C@@H]3[C@H]([C@@H](O)[C@H](O)[C@@H](CO)O3)O[C@@H]3[C@H]([C@H](O)[C@@H](CO)O3)O)C4=CC2=C1 BGTFCAQCKWKTRL-YDEUACAXSA-N 0.000 description 6
- 229950004257 ristocetin Drugs 0.000 description 6
- DHMQDGOQFOQNFH-UHFFFAOYSA-N Glycine Chemical compound NCC(O)=O DHMQDGOQFOQNFH-UHFFFAOYSA-N 0.000 description 4
- 230000005540 biological transmission Effects 0.000 description 4
- 238000004220 aggregation Methods 0.000 description 3
- 230000002776 aggregation Effects 0.000 description 3
- 238000005119 centrifugation Methods 0.000 description 3
- 238000010790 dilution Methods 0.000 description 3
- 239000012895 dilution Substances 0.000 description 3
- 239000008363 phosphate buffer Substances 0.000 description 3
- 238000010186 staining Methods 0.000 description 3
- SXRSQZLOMIGNAQ-UHFFFAOYSA-N Glutaraldehyde Chemical compound O=CCCCC=O SXRSQZLOMIGNAQ-UHFFFAOYSA-N 0.000 description 2
- 239000004471 Glycine Substances 0.000 description 2
- 102000008100 Human Serum Albumin Human genes 0.000 description 2
- 108091006905 Human Serum Albumin Proteins 0.000 description 2
- 229930006000 Sucrose Natural products 0.000 description 2
- CZMRCDWAGMRECN-UGDNZRGBSA-N Sucrose Chemical compound O[C@H]1[C@H](O)[C@@H](CO)O[C@@]1(CO)O[C@@H]1[C@H](O)[C@@H](O)[C@H](O)[C@@H](CO)O1 CZMRCDWAGMRECN-UGDNZRGBSA-N 0.000 description 2
- 238000004108 freeze drying Methods 0.000 description 2
- 150000002500 ions Chemical class 0.000 description 2
- 239000002244 precipitate Substances 0.000 description 2
- GHMLBKRAJCXXBS-UHFFFAOYSA-N resorcinol Chemical compound OC1=CC=CC(O)=C1 GHMLBKRAJCXXBS-UHFFFAOYSA-N 0.000 description 2
- 230000035945 sensitivity Effects 0.000 description 2
- 230000002269 spontaneous effect Effects 0.000 description 2
- 239000005720 sucrose Substances 0.000 description 2
- 239000006228 supernatant Substances 0.000 description 2
- 208000011580 syndromic disease Diseases 0.000 description 2
- ZFFMLCVRJBZUDZ-UHFFFAOYSA-N 2,3-dimethylbutane Chemical group CC(C)C(C)C ZFFMLCVRJBZUDZ-UHFFFAOYSA-N 0.000 description 1
- QFVHZQCOUORWEI-UHFFFAOYSA-N 4-[(4-anilino-5-sulfonaphthalen-1-yl)diazenyl]-5-hydroxynaphthalene-2,7-disulfonic acid Chemical compound C=12C(O)=CC(S(O)(=O)=O)=CC2=CC(S(O)(=O)=O)=CC=1N=NC(C1=CC=CC(=C11)S(O)(=O)=O)=CC=C1NC1=CC=CC=C1 QFVHZQCOUORWEI-UHFFFAOYSA-N 0.000 description 1
- KRKNYBCHXYNGOX-UHFFFAOYSA-K Citrate Chemical compound [O-]C(=O)CC(O)(CC([O-])=O)C([O-])=O KRKNYBCHXYNGOX-UHFFFAOYSA-K 0.000 description 1
- 102100026735 Coagulation factor VIII Human genes 0.000 description 1
- 101100478173 Drosophila melanogaster spen gene Proteins 0.000 description 1
- 101000911390 Homo sapiens Coagulation factor VIII Proteins 0.000 description 1
- 101100513476 Mus musculus Spen gene Proteins 0.000 description 1
- 108091005804 Peptidases Proteins 0.000 description 1
- 241000083869 Polyommatus dorylas Species 0.000 description 1
- 239000004365 Protease Substances 0.000 description 1
- 102100037486 Reverse transcriptase/ribonuclease H Human genes 0.000 description 1
- 230000009286 beneficial effect Effects 0.000 description 1
- 230000003115 biocidal effect Effects 0.000 description 1
- 239000003086 colorant Substances 0.000 description 1
- 239000012141 concentrate Substances 0.000 description 1
- 238000003745 diagnosis Methods 0.000 description 1
- 230000000694 effects Effects 0.000 description 1
- 210000003743 erythrocyte Anatomy 0.000 description 1
- DWYMPOCYEZONEA-UHFFFAOYSA-L fluoridophosphate Chemical compound [O-]P([O-])(F)=O DWYMPOCYEZONEA-UHFFFAOYSA-L 0.000 description 1
- 239000008098 formaldehyde solution Substances 0.000 description 1
- 238000007710 freezing Methods 0.000 description 1
- 230000008014 freezing Effects 0.000 description 1
- 238000001502 gel electrophoresis Methods 0.000 description 1
- 239000011521 glass Substances 0.000 description 1
- 238000005259 measurement Methods 0.000 description 1
- WSFSSNUMVMOOMR-NJFSPNSNSA-N methanone Chemical compound O=[14CH2] WSFSSNUMVMOOMR-NJFSPNSNSA-N 0.000 description 1
- 239000000203 mixture Substances 0.000 description 1
- 239000000985 reactive dye Substances 0.000 description 1
- YWOPZILGDZKFFC-DFWYDOINSA-M sodium;(2s)-2,5-diamino-5-oxopentanoate Chemical compound [Na+].[O-]C(=O)[C@@H](N)CCC(N)=O YWOPZILGDZKFFC-DFWYDOINSA-M 0.000 description 1
- 239000000243 solution Substances 0.000 description 1
- 208000010110 spontaneous platelet aggregation Diseases 0.000 description 1
- 238000003756 stirring Methods 0.000 description 1
- 239000003634 thrombocyte concentrate Substances 0.000 description 1
- 230000001960 triggered effect Effects 0.000 description 1
- YXZRCLVVNRLPTP-UHFFFAOYSA-J turquoise blue Chemical compound [Na+].[Na+].[Na+].[Na+].[Cu+2].NC1=NC(Cl)=NC(NC=2C=C(NS(=O)(=O)C3=CC=4C(=C5NC=4NC=4[N-]C(=C6C=CC(=CC6=4)S([O-])(=O)=O)NC=4NC(=C6C=C(C=CC6=4)S([O-])(=O)=O)NC=4[N-]C(=C6C=CC(=CC6=4)S([O-])(=O)=O)N5)C=C3)C(=CC=2)S([O-])(=O)=O)=N1 YXZRCLVVNRLPTP-UHFFFAOYSA-J 0.000 description 1
- 238000005406 washing Methods 0.000 description 1
- XLYOFNOQVPJJNP-UHFFFAOYSA-N water Substances O XLYOFNOQVPJJNP-UHFFFAOYSA-N 0.000 description 1
Classifications
-
- G—PHYSICS
- G01—MEASURING; TESTING
- G01N—INVESTIGATING OR ANALYSING MATERIALS BY DETERMINING THEIR CHEMICAL OR PHYSICAL PROPERTIES
- G01N33/00—Investigating or analysing materials by specific methods not covered by groups G01N1/00 - G01N31/00
- G01N33/48—Biological material, e.g. blood, urine; Haemocytometers
- G01N33/50—Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing
- G01N33/86—Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing involving blood coagulating time or factors, or their receptors
-
- C—CHEMISTRY; METALLURGY
- C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
- C12Q—MEASURING OR TESTING PROCESSES INVOLVING ENZYMES, NUCLEIC ACIDS OR MICROORGANISMS; COMPOSITIONS OR TEST PAPERS THEREFOR; PROCESSES OF PREPARING SUCH COMPOSITIONS; CONDITION-RESPONSIVE CONTROL IN MICROBIOLOGICAL OR ENZYMOLOGICAL PROCESSES
- C12Q1/00—Measuring or testing processes involving enzymes, nucleic acids or microorganisms; Compositions therefor; Processes of preparing such compositions
- C12Q1/56—Measuring or testing processes involving enzymes, nucleic acids or microorganisms; Compositions therefor; Processes of preparing such compositions involving blood clotting factors, e.g. involving thrombin, thromboplastin, fibrinogen
-
- G—PHYSICS
- G01—MEASURING; TESTING
- G01N—INVESTIGATING OR ANALYSING MATERIALS BY DETERMINING THEIR CHEMICAL OR PHYSICAL PROPERTIES
- G01N2333/00—Assays involving biological materials from specific organisms or of a specific nature
- G01N2333/435—Assays involving biological materials from specific organisms or of a specific nature from animals; from humans
- G01N2333/745—Assays involving non-enzymic blood coagulation factors
- G01N2333/755—Factors VIII, e.g. factor VIII C [AHF], factor VIII Ag [VWF]
-
- Y—GENERAL TAGGING OF NEW TECHNOLOGICAL DEVELOPMENTS; GENERAL TAGGING OF CROSS-SECTIONAL TECHNOLOGIES SPANNING OVER SEVERAL SECTIONS OF THE IPC; TECHNICAL SUBJECTS COVERED BY FORMER USPC CROSS-REFERENCE ART COLLECTIONS [XRACs] AND DIGESTS
- Y10—TECHNICAL SUBJECTS COVERED BY FORMER USPC
- Y10T—TECHNICAL SUBJECTS COVERED BY FORMER US CLASSIFICATION
- Y10T436/00—Chemistry: analytical and immunological testing
- Y10T436/10—Composition for standardization, calibration, simulation, stabilization, preparation or preservation; processes of use in preparation for chemical testing
- Y10T436/101666—Particle count or volume standard or control [e.g., platelet count standards, etc.]
Landscapes
- Health & Medical Sciences (AREA)
- Life Sciences & Earth Sciences (AREA)
- Chemical & Material Sciences (AREA)
- Engineering & Computer Science (AREA)
- Hematology (AREA)
- Molecular Biology (AREA)
- Organic Chemistry (AREA)
- Immunology (AREA)
- Biochemistry (AREA)
- Wood Science & Technology (AREA)
- Urology & Nephrology (AREA)
- Zoology (AREA)
- Microbiology (AREA)
- Biomedical Technology (AREA)
- Physics & Mathematics (AREA)
- Analytical Chemistry (AREA)
- Biotechnology (AREA)
- General Health & Medical Sciences (AREA)
- Proteomics, Peptides & Aminoacids (AREA)
- Cell Biology (AREA)
- Neurosurgery (AREA)
- Biophysics (AREA)
- General Physics & Mathematics (AREA)
- Medicinal Chemistry (AREA)
- Food Science & Technology (AREA)
- Pathology (AREA)
- Bioinformatics & Cheminformatics (AREA)
- General Engineering & Computer Science (AREA)
- Genetics & Genomics (AREA)
- Investigating Or Analysing Biological Materials (AREA)
- Measuring Or Testing Involving Enzymes Or Micro-Organisms (AREA)
- Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
Priority Applications (12)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| DE19813141894 DE3141894A1 (de) | 1981-10-22 | 1981-10-22 | Reagenz fuer die bestimmung des ristocetin-cofaktors (v. willebrand-faktor) |
| US06/430,748 US4510126A (en) | 1981-10-22 | 1982-09-30 | Reagent for the determination of ristocetin cofactor (v.Willebrand factor) |
| NZ202239A NZ202239A (en) | 1981-10-22 | 1982-10-20 | Reagent for the determination of ristocetin cofactor |
| AT82109676T ATE12839T1 (de) | 1981-10-22 | 1982-10-20 | Reagenz fuer die bestimmung des ristocetincofaktors (v. willibrand-faktor). |
| EP82109676A EP0078451B1 (de) | 1981-10-22 | 1982-10-20 | Reagenz für die Bestimmung des Ristocetin-Cofaktors (v. Willibrand-Faktor) |
| DE8282109676T DE3263152D1 (en) | 1981-10-22 | 1982-10-20 | Reagents for determining the ristocetin cofactor (von willebrand's factor) |
| ES516672A ES516672A0 (es) | 1981-10-22 | 1982-10-20 | "procedimiento para preparar un agente para la determinacion del cofactor de ristocetina". |
| CA000413895A CA1191771A (en) | 1981-10-22 | 1982-10-21 | Reagent for the determination of ristocetin cofactor (v. willebrand factor) |
| NO823508A NO160554C (no) | 1981-10-22 | 1982-10-21 | Reagens for bestemmelse av ristocetin-kofaktoren (willebrand-faktor). |
| AU89674/82A AU549733B2 (en) | 1981-10-22 | 1982-10-21 | Factor v111 determination using restocetin, platelets, protease inhibitor |
| DK468582A DK155766C (da) | 1981-10-22 | 1982-10-21 | Reagens til bestemmelse af ristocetin-cofaktor (v. willebrand-faktor) |
| JP57183814A JPS5878599A (ja) | 1981-10-22 | 1982-10-21 | リストセチンコフアクタ−測定用試薬 |
Applications Claiming Priority (1)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| DE19813141894 DE3141894A1 (de) | 1981-10-22 | 1981-10-22 | Reagenz fuer die bestimmung des ristocetin-cofaktors (v. willebrand-faktor) |
Publications (1)
| Publication Number | Publication Date |
|---|---|
| DE3141894A1 true DE3141894A1 (de) | 1983-05-05 |
Family
ID=6144625
Family Applications (2)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| DE19813141894 Withdrawn DE3141894A1 (de) | 1981-10-22 | 1981-10-22 | Reagenz fuer die bestimmung des ristocetin-cofaktors (v. willebrand-faktor) |
| DE8282109676T Expired DE3263152D1 (en) | 1981-10-22 | 1982-10-20 | Reagents for determining the ristocetin cofactor (von willebrand's factor) |
Family Applications After (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| DE8282109676T Expired DE3263152D1 (en) | 1981-10-22 | 1982-10-20 | Reagents for determining the ristocetin cofactor (von willebrand's factor) |
Country Status (11)
Cited By (1)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| US6610291B2 (en) | 1999-12-29 | 2003-08-26 | Dade Behring Marburg Gmbh | Ready-to-use ristocetin cofactor test reagent possessing long-term stability |
Families Citing this family (8)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| EP0186476A3 (en) * | 1984-12-21 | 1987-10-21 | Hemochek Corporation | Diagnostic kit and method for assaying blood components |
| JPH03193735A (ja) * | 1989-12-22 | 1991-08-23 | Shionogi & Co Ltd | グリコペプチド系抗生物質の安定化組成物 |
| DE4016885A1 (de) * | 1990-05-25 | 1991-11-28 | Behringwerke Ag | Methode zur bestimmung des von-willebrand-faktors |
| DK0642301T3 (da) * | 1992-05-29 | 2003-06-23 | Univ North Carolina | Farmaceutisk acceptable fikserede, tørrede humane blodplader |
| DE10013377A1 (de) * | 2000-03-17 | 2001-09-20 | Dade Behring Marburg Gmbh | Induzierte Aggregation und Agglutination von Plättchen |
| US20060074014A1 (en) * | 2002-11-18 | 2006-04-06 | Vicuron Pharmaceuticals Inc. | Dalbavancin compositions for treatment of bacterial infections |
| WO2005041897A2 (en) * | 2003-10-31 | 2005-05-12 | Point Biomedical Corporation | Reconstitutable microsphere compositions useful as ultrasonic contrast agents |
| DE102006019520A1 (de) * | 2006-04-27 | 2007-11-08 | Dade Behring Marburg Gmbh | Verfahren zur Bestimmung hoher Ristocetin-Kofaktor-Aktivitäten des von-Willebrand-Faktors |
Family Cites Families (3)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| DE2546166A1 (de) * | 1975-10-15 | 1977-04-28 | Behringwerke Ag | Gegerbte thrombozyten |
| US4287087A (en) * | 1977-02-25 | 1981-09-01 | Research Triangle Institute | Fixed-dried blood platelets |
| US4145185A (en) * | 1977-02-25 | 1979-03-20 | Research Triangle Institute | Reagents for screening tests and bioassay of von Willebrand's factor (platelet aggregating factor) in blood plasmas |
-
1981
- 1981-10-22 DE DE19813141894 patent/DE3141894A1/de not_active Withdrawn
-
1982
- 1982-09-30 US US06/430,748 patent/US4510126A/en not_active Expired - Lifetime
- 1982-10-20 ES ES516672A patent/ES516672A0/es active Granted
- 1982-10-20 EP EP82109676A patent/EP0078451B1/de not_active Expired
- 1982-10-20 DE DE8282109676T patent/DE3263152D1/de not_active Expired
- 1982-10-20 NZ NZ202239A patent/NZ202239A/en unknown
- 1982-10-20 AT AT82109676T patent/ATE12839T1/de not_active IP Right Cessation
- 1982-10-21 JP JP57183814A patent/JPS5878599A/ja active Granted
- 1982-10-21 AU AU89674/82A patent/AU549733B2/en not_active Ceased
- 1982-10-21 CA CA000413895A patent/CA1191771A/en not_active Expired
- 1982-10-21 DK DK468582A patent/DK155766C/da not_active IP Right Cessation
- 1982-10-21 NO NO823508A patent/NO160554C/no unknown
Cited By (2)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| US6610291B2 (en) | 1999-12-29 | 2003-08-26 | Dade Behring Marburg Gmbh | Ready-to-use ristocetin cofactor test reagent possessing long-term stability |
| EP1130402A3 (de) * | 1999-12-29 | 2004-02-11 | Dade Behring Marburg GmbH | Gebrauchsfertiges langzeitstabiles Ristocetin Cofactor Testreagenz |
Also Published As
| Publication number | Publication date |
|---|---|
| NO160554B (no) | 1989-01-16 |
| ES8307376A1 (es) | 1983-06-16 |
| DK155766C (da) | 1989-09-25 |
| ES516672A0 (es) | 1983-06-16 |
| EP0078451A1 (de) | 1983-05-11 |
| AU549733B2 (en) | 1986-02-06 |
| EP0078451B1 (de) | 1985-04-17 |
| JPS5878599A (ja) | 1983-05-12 |
| CA1191771A (en) | 1985-08-13 |
| US4510126A (en) | 1985-04-09 |
| ATE12839T1 (de) | 1985-05-15 |
| JPH0322590B2 (GUID-C5D7CC26-194C-43D0-91A1-9AE8C70A9BFF.html) | 1991-03-27 |
| DK155766B (da) | 1989-05-08 |
| DE3263152D1 (en) | 1985-05-23 |
| NO823508L (no) | 1983-04-25 |
| NO160554C (no) | 1989-04-26 |
| AU8967482A (en) | 1983-04-28 |
| NZ202239A (en) | 1985-07-12 |
| DK468582A (da) | 1983-04-23 |
Similar Documents
| Publication | Publication Date | Title |
|---|---|---|
| EP0158254B1 (de) | Reagenz zur Bestimmung der Thromboplastinzeit | |
| Zimmerman et al. | Determination of the von Willebrand's disease antigen (factor VIII-related antigen) in plasma by quantitative immunoetectrophoresis | |
| DE2548963C3 (de) | Verfahren und Mittel zur Bestimmung der Aktivität von Creatinkinase-MB | |
| Price et al. | Human atrial and ventricular myosin light-chains subunits in the adult and during development | |
| KR880001533B1 (ko) | 항원 항체반응의 측정방법 및 그 시약 | |
| DE3209149A1 (de) | Verfahren zur gemeinsamen immunologischen bestimmung von prokollagen-peptid (typ iii) und prokollagen-peptid col 1 (typ iii) und verfahren zur herstellung von anti-prokollagen-peptid col 1 (typ iii)-serum | |
| Austin et al. | Stonefish venom: some biochemical and chemical observations | |
| DE69534294T2 (de) | Mess-system unter verwendung von vollblut | |
| EP0537490A2 (de) | Funktioneller Test und Reagenz zur Bestimmung von Fibrinogen | |
| DE3141894A1 (de) | Reagenz fuer die bestimmung des ristocetin-cofaktors (v. willebrand-faktor) | |
| DE3425186A1 (de) | Humanproteine, verfahren zu deren herstellung und diese enthaltende testkits | |
| Rüchel et al. | Molecular forms and hydrodynamic properties of acetylcholine receptor from electric tissue | |
| DE3311287A1 (de) | Verfahren zur fotometrischen bestimmung der aktivierten partiellen thromboplastinzeit und reagenz dazu | |
| DE68912477T2 (de) | Verfahren zum messen der biologischen wirkung von antithrombin iii und reagenzien zu dessen messung. | |
| WO1998044352A1 (de) | REAGENS ZUR BESTIMMUNG DER aPTT | |
| US5039619A (en) | Method for detecting characteristic markers of disease in biological fluids | |
| Kinersly et al. | Electrophoretic Study of Saliva | |
| DE2638250C2 (de) | Diagnostisches Verfahren zum Bestimmen der Anwesenheit oder Abwesenheit eines spezifischen Proteins in einer biologischen Probe, sowie Vorrichtung zur Durchführung des Verfahrens | |
| EP1130402B1 (de) | Gebrauchsfertiges langzeitstabiles Ristocetin Cofactor Testreagenz | |
| EP0253255A2 (de) | Verfahren und Testkit zum Nachweis von Fibrinmonomeren im Blut | |
| EP0431567B1 (de) | Verfahren zum Nachweis eines kleinzelligen Bronchial-Karzinoms | |
| EP0013306B1 (de) | Verfahren zur Bestimmung eines opsonierenden oberflächenbindenden alpha-2-Glykoproteins | |
| EP0188008A2 (de) | Verfahren zur Bestimmung der Aktivität des Komplementsystems des Blutes | |
| Nürnberger et al. | Identification of the heterozygotes for deficiency of the β-subunit of the eighth component of complement by reduced levels of C8β and increased amounts of free C8α-γ | |
| DE1943881C3 (de) | Verfahren zur quantitativen Bestimmung der Thrombinaktivität in Blutplasma und dessen Fraktionen |
Legal Events
| Date | Code | Title | Description |
|---|---|---|---|
| 8130 | Withdrawal |